ArriVent BioPharma, Inc. 4 filing

Filed 2026-02-03 · Report date 2025-12-10 · 2025

View Original SEC Filing

Filing metadata

Accession number: 0000902664-26-000675
Form type: 4
CIK: 0001868279
Primary document: https://www.sec.gov/Archives/edgar/data/1868279/000090266426000675/xslF345X05/ownership.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for ArriVent BioPharma, Inc..

Reported financial metrics

Metric	Current	Prior	Change